EUDA Health Holdings Limited (EUDAW) Comparison with companies in other sectors?

EUDA Health Holdings Limited has a share price of 37.16M. You can analyze EUDA Health Holdings Limited (EUDAW) competitors across different market sectors through stock heatmaps.

What are EUDAW's NET and operating margins?

EUDA Health Holdings Limited (EUDAW) operating margin is around -8.57, and net profit margin is approximately -8.82 as of the latest reports.

In what way does EUDAW's earnings per share (EPS) trend reflect its financial momentum?

EUDA Health Holdings Limited (EUDAW) EPS is N/A (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for EUDA Health Holdings Limited is N/A, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for EUDA Health Holdings Limited?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for EUDA Health Holdings Limited like P/E which is -5.42, P/B which is -35.74, and PEG which is -0.09. Compare them with sector averages to evaluate if the stock is priced fairly.

EUDA Health Holdings Limited

EUDAW•NASDAQ

Healthcare

Medical - Healthcare Information Services

$0.10

$-0.03(-22.74%)

Fundamental Analysis of EUDA Health Holdings Limited (EUDAW)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

P/E Ratio

ROE

3.05%

Net Margin

-8.82%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$2.97M

Shares OutstandingTotal number of shares issued

$37.16M

Book Value/ShareNet worth per share

$-0.09

Revenue/ShareAnnual revenue per share

$0.07

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

Net MarginNet income as percentage of revenue

-881.94%

Operating MarginOperating income as percentage of revenue

-856.66%

ROEReturn on shareholders' equity

304.61%

ROAReturn on total assets

-991.04%

ROCEReturn on capital employed

669.08%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-0.04

Cash/ShareCash and equivalents per share

$0.008

FCF YieldFree cash flow as percentage of market cap

-1.06%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for EUDAWFinancial Ratios Analysis details for EUDAW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for EUDAWSector Benchmarking details for EUDAW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for EUDA Health Holdings Limited Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of EUDA Health Holdings Limited. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account EUDA Health Holdings Limited's unique business strengths and challenges.

Key Financial Metrics for EUDA Health Holdings Limited

For EUDA Health Holdings Limited, essential financial indicators include EPS -, PE -, and ROE 3.05. These key ratios reveal insights into EUDA Health Holdings Limited's profitability, valuation, and operational health. Understanding these metrics enables you to compare EUDA Health Holdings Limited with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of EUDA Health Holdings Limited

Metrics like Net Margin -881.94% and ROA -991.04% shed light on how well EUDA Health Holdings Limited is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether EUDA Health Holdings Limited can sustain its operations and continue growing in the future.

Valuation and Market Position of EUDA Health Holdings Limited

Using ratios such as P/B Ratio -35.74 and PEG Ratio -0.09, investors can assess whether EUDA Health Holdings Limited is appropriately valued based on its financials and growth potential. These figures, combined with EUDA Health Holdings Limited's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for EUDA Health Holdings Limited

Financial health indicators, such as Debt/Equity Ratio -0.50 and Cash Flow $-0.04, provide a snapshot of EUDA Health Holdings Limited's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like EUDA Health Holdings Limited, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for EUDA Health Holdings Limited

Investing in EUDA Health Holdings Limited based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at EUDA Health Holdings Limited focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;